Clinical trial
A Randomized Phase 3 Study to Evaluate 2 Different Formulations of Romosozumab in Postmenopausal Women With Osteoporosis
Purpose of this study is to evaluate the 2 formulations of Romosozumab in Postmenopausal Women With Osteoporosis.
| Category | Value |
|---|---|
| Study start date | 2013-12-10 |